Home > Insider Trading > Filing (0001628280-24-011050)

Filing Details

Accession Number:: 0001628280-24-011050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-13 21:21:40
Reporting Period:: 2024-03-11

Accepted Time:: 2024-03-13 21:21:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671284	Neuehealth Inc.	NEUE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1381037	Iii Lawrence George Mikan	C/O Neuehealth, Inc. 8000 Norman Center Drive, Suite 900 Minneapolis MN 55437	Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-03-11	2,664	$8.11	80,723	No	4	S	Direct
Common Stock	Disposition	2024-03-12	1,598	$7.76	79,125	No	4	S	Direct
Common Stock	Disposition	2024-03-13	3,463	$7.30	75,662	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.85 and $8.38 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 and $8.10 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.11 and $7.52 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.